In line with its commitment to environmental sustainability, Bioiberica, a manufacturer of the active pharmaceutical ingredient (API) Heparin, has set a series of targets that include obtaining 100% renewable electricity by 2024, and reducing greenhouse gas (GHG) emissions by 30% before 2030.
These targets are aligned with scopes 1 and 2 of the Greenhouse Gas (GHG) Protocol.
By pursuing a low-emission economy, reducing water consumption, and expanding renewable energy initiatives, Bioiberica aims to safeguard environmental resources.
Luis Solera, the firm's CEO, emphasised the commitment to a circular bioeconomy, where manufacturing processes are designed to minimise water, energy, and auxiliary raw material consumption.
Solera stated: ”Our new Climate Strategy Report encompasses a comprehensive inventory of our current greenhouse gas emissions, along with the targets we have set and the milestones we have achieved thus far.
“Additionally, the report outlines our strategies for addressing future challenges as part of our journey toward climate neutrality, focusing on business opportunities and more sustainable practices.”
Climate Strategy Report
Energy efficiency is a key component of Bioiberica's climate strategy, with the maintaining efforts to enhance energy use since attaining ISO 50001 certification in 2012.
To meet sustainability targets, the company aligns its actions with the recommendations of the Task Force on Climate-Related Financial Disclosures (TCFD).
The company's actions are linked to global targets defined to achieve the UN’s Sustainable Development Goals (SDGs), particularly SDG-7 (Affordable and Clean Energy), SDG-12 (Responsible Consumption and Production), and SDG-13 (Climate Action), for which Bioiberica is in the certification process.
By implementing an energy management system, Bioiberica identifies opportunities for improving energy efficiency and enacts specific changes to reduce consumption.
Other improvements include a revamped lighting system, installation of energy-efficient factory equipment like upgraded boilers and cooling systems, leak reduction measures, and optimisation of production processes.
Additionally, the company's report outlines plan to source 100% of its electricity from renewable sources by 2024.
To achieve this objective, energy efficiency criteria will be integrated into equipment procurement and service acquisition processes, and the installation of 1,000 kW of photovoltaic power for self-consumption is already underway.
In addition to energy conservation, water usage remains a top priority for Bioiberica, which obtained ISO 14001 and European Eco-Management and Audit Scheme (EMAS) certifications in 1997 and 1999 respectively.
Approximately 21% of Bioiberica's wastewater is repurposed for various manufacturing activities, and the company aims to raise this figure to 50%.
Bioiberica’s plans involve reducing water usage per tonne of product and ensuring that all operations adhere to local water resource regulations, resulting in clean returned water.
The company also intends to collaborate with local communities to raise awareness about these initiatives and ensure access to repurposed water.
Solera noted: "As the climate emergency intensifies, we are taking decisive action to minimize Bioiberica's environmental impact.
“We acknowledge the challenges that lie ahead, and we recognise that achieving complete climate neutrality by 2050 requires significant effort. Nonetheless, we remain steadfast in our commitment to protect and sustain our planet, ensuring its viability as a habitat for all life forms—people, animals, and plants—for years to come.”